World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
41198
World Ranking
11575
National Ranking
49

Lars Gullestad publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars Gullestad sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 645 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lars Gullestad D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Gullestad sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lars Gullestad is affiliated with Oslo University Hospital in Norway. Their research primarily focuses on the field of Medicine, with notable contributions in Cardiology and Cardiovascular Medicine, Surgery, Immunology, Pulmonary and Respiratory Medicine, and Biomedical Engineering.

The main topics of their work include:

  • Transplantation: Methods and Outcomes
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Mechanical Circulatory Support Devices
  • Obstructive Sleep Apnea Research
  • Acute Myocardial Infarction Research
  • Atherosclerosis and Cardiovascular Diseases

Lars Gullestad has published extensively, with frequent appearances in several notable publication venues, such as:

  • The Journal of Heart and Lung Transplantation
  • European Heart Journal
  • Journal of the American College of Cardiology
  • ESC Heart Failure
  • Clinical Transplantation

Recent papers include:

  • "Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction," 2021, Journal of the American College of Cardiology
  • "Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes," 2020, European Heart Journal
  • "Targeting the Inflammasome in Cardiovascular Disease," 2021, JACC Basic to Translational Science
  • "Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction," 2021, Journal of the American College of Cardiology
  • "Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial," 2021, American Journal of Respiratory and Critical Care Medicine

Gullestad collaborates frequently with several coauthors, including:

  • Kaspar Broch
  • Einar Gude
  • Thor Ueland
  • Katrine Rolid
  • Arne K. Andreassen

Best Publications

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

    Aldo P. Maggioni;Ulf Dahlstrom;Gerasimos Filippatos;Ovidiu Chioncel

  • Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes

    Pål Aukrust;Fredrik Müller;Thor Ueland;Trude Berget

  • Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.

    Tuva B. Dahl;Arne Yndestad;Mona Skjelland;Erik Øie

  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

    Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen

  • EURObservational Research Programme:The heart Failure Pilot Survey (ESC-HF Pilot)

    Aldo P. Maggioni;Ulf Dahlstrom;Gerasimos Filippatos;Ovidiu Chioncel

  • Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

    Pål Aukrust;Thor Ueland;Fredrik Müller;Arne K. Andreassen

  • Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

    Lars Gullestad;Halfdan Aass;Jan G. Fjeld;Lisbeth Wikeby

  • Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial

    Nicolai Tegn;Nicolai Tegn;Michael Abdelnoor;Lars Aaberge;Knut Endresen

  • Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.

    M. Trøseid;T. Ueland;T. Ueland;J. R. Hov;A. Svardal

  • A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

    George D. Dangas;Jan G.P. Tijssen;Jochen Wöhrle;Lars Søndergaard

  • Inflammatory cytokines in heart failure: mediators and markers.

    Lars Gullestad;Thor Ueland;Leif Erik Vinge;Alexandra Finsen

  • Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.

    Ola Kleveland;Gabor Kunszt;Gabor Kunszt;Marte Bratlie;Marte Bratlie;Thor Ueland

  • Systemic inflammation in heart failure--the whys and wherefores.

    Arne Yndestad;Jan Kristian Damås;Erik Oie;Thor Ueland

  • Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure

    Jonathan Myers;Lars Gullestad;Randall Vagelos;Dat Do

  • Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

    Arne Yndestad;Linn Landrø;Thor Ueland;Christen P. Dahl

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    Ake Hjalmarson;Sidney Goldstein Björn Fagerberg;Hans Wredel;Finn Waagstein

  • Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

    Lars Gullestad;Pål Aukrust;Thor Ueland;Terje Espevik

Frequent Co-Authors

Pål Aukrust
Pål Aukrust Oslo University Hospital
Thor Ueland
Thor Ueland University of Oslo
Arne Yndestad
Arne Yndestad Oslo University Hospital
John Kjekshus
John Kjekshus University of Oslo
Stig S. Frøland
Stig S. Frøland University of Oslo
Bente Halvorsen
Bente Halvorsen University of Oslo
John J.V. McMurray
John J.V. McMurray University of Glasgow
Thor Edvardsen
Thor Edvardsen Oslo University Hospital
John G.F. Cleland
John G.F. Cleland University of Glasgow
Rolf K. Berge
Rolf K. Berge University of Bergen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing Medicine in the USA is highly competitive, there are other rewarding health care pathways available through online study. Many students start their careers with nursing, which offers flexible entry points and excellent job prospects nationwide. Exploring online nurse practitioner programs is a practical way to rise into advanced practice roles without pausing your professional life.

Prospective nurses concerned about costs can choose among the cheapest bsn programs online. These accredited offerings allow you to earn a quality bachelor's degree in nursing (BSN) at a fraction of the price of on-campus programs. For those already holding their RN license, several affordable rn to bsn programs enable further advancement and increased earning potential.

Ambitious learners aiming for leadership, research, or teaching can also consider online nursing doctoral programs. These pathways open doors to academic careers, policy-making, and high-level health care positions. No matter your background, online degrees offer accessible and flexible routes to impactful health careers in the USA.

Best Scientists Citing Lars Gullestad

Trending Scientists

Recently Published Articles